Skip to main content
SpringerLink
Log in

Extracorporeal Shockwave Therapy in Peyronie’s Disease

  • Chapter
Book cover Peyronie’S Disease

Part of the book series: Current Clinical Urology ((CCU))

  • 694 Accesses

Abstract

Extracorporeal shockwave therapy (ESWT) has been on the rise for the treatment of Peyronie’s disease. There have been 21 original papers, 1 meta-analysis, and 2 review articles published. Analyzing these studies systematically, ESWT seems to have an effect on penile pain during erection and on the improvement of sexual function. It seems that pain resolves faster after ESWT treatment than during the course of natural history. The effect on plaque size and penile curvature is less impressive. The most recent studies do not provide evidence that ESWT has an effect on curvature and plaque size. Despite the lack of severe side effects, the data concerning efficacy published to date do not justify recognizing ESWT as an evidence-based, standard procedure for the treatment of Peyronie’s disease.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 289.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Levine LA. Review of current nonsurgical management of Peyronie’ s disease. Int J Impot Res 2003; 15(suppl5): S113–S120.

    Article  PubMed  Google Scholar 

  2. Mynderse LA, Monga M. Oral therapy for Peyronie’s disease. Int J Impot Res 2002; 14: 340–344.

    Article  PubMed  CAS  Google Scholar 

  3. Levine LA, Lenting EL. A surgical algorithm for the treatment of Peyronie’s disease. JUrol 1997; 158: 2149–2152.

    CAS  Google Scholar 

  4. Bellorofonte C, Ruoppolo M, Tura M, et al. Possibility of using the piezoelectric lithotriptor in the treatment of severe cavernoufibrosis [in Italian]. Arch Ital Urol Nephrol 1989; 61: 417–422.

    CAS  Google Scholar 

  5. Butz M, Teichert HM. Treatment of Peyronie’s disease (PD) by extracorporeal shock waves (ESW). J Urol 1998; 159(suppl 5): 118. Abstract 457.

    Google Scholar 

  6. Abdel-Salam Y, Budair Z, Renner C, et al. Treatment of Peyronie’s disease by extracorporeal shock wave therapy: evaluation of our preliminary results. J Endourol 1999; 13: 549–552.

    Article  PubMed  CAS  Google Scholar 

  7. Baumann M, Tauber R. Peyronie’s disease: Extracorporeal shock wave therapy (EPT) as a new treatment [in German]. Akt Urol 1998; 29: 1–5.

    Google Scholar 

  8. Baumann M, Böhme H, Tauber R. Extracorporeal shock wave therapy (ESWT) in combination with local verapamil injections in the treatment of IPP (induratio penis plastica) [in German]. Akt Urol 2001; 32(suppl 1): 61–64.

    Article  Google Scholar 

  9. Butz M. Extracorporeal shock wave therapy (ESWT) in induratio penis plastica—development and topical ranking [in German]. Akt Urol 2001; 32(suppl 1): 55–57.

    Article  Google Scholar 

  10. Colombo F, Massimiliano N. Shock waves in the treatment of La Peyronie’s disease. Outcomes evaluation by ultrasonography. La Peyronie’s disease [in Italian]. Arch Ital Urol Androl 2000; 72; 388–391.

    PubMed  CAS  Google Scholar 

  11. Hamm R, Mclarty E, Ashdown J, Natale S, Dickinson A. Peyronie’s disease—the Plymouth experience of extracorporeal shock wave treatment. BJU Int 2001; 87: 849–852.

    Article  PubMed  CAS  Google Scholar 

  12. Hauck EW, Altinkilic BM, Ludwig M, et al. Extracorporeal shock-wave therapy (ESWT) in the treatment of Peyronie’s disease—first results of a case-controlled approach. Eur Urol 2000; 38: 663–670.

    Article  PubMed  CAS  Google Scholar 

  13. Hauck EW, Hauptmann A, Bschleipfer T, Schmelz HU, Altinkilic BM, Weidner W. Questionable efficacy of extracorporeal shock wave therapy in Peyronie’s disease: results of a prospective approach. JUrol 2004; 171:269–299.

    Google Scholar 

  14. Husain J, Lynn NNK, Jones DK, Collins GN, O’Reilly PH. Extracorporeal shock wave therapy in the management of Peyronie’s disease: initial experience. BJU Int 2000; 86: 466–468.

    Article  PubMed  CAS  Google Scholar 

  15. Kiyota H, Ohishi Y, Asano K, et al. Extracorporeal shock wave treatment for Peyronie’s disease using EDAP LT-02: preliminary results. Int J Urol 2002; 9: 110–113.

    Article  PubMed  Google Scholar 

  16. Lebret T, Herve JM, Lugane PM, et al. Extracorporeal shock wave lithotripsy (ESWL) in the treatment of la Peyronie disease. Use of a standardized lithotriptor (Siemens multilinie) on “young” plaques (less than 6 mo) [in French]. Prog Urol 2000; 10: 65–70.

    PubMed  CAS  Google Scholar 

  17. Lebret T, Loison G, Hervé JM, et al. Extracorporeal shock wave therapy in the treatment of Peyronie’s disease: experience with standard lithotriptor (Siemens-multiline). Urology 2002; 59: 657–661.

    Article  PubMed  Google Scholar 

  18. Manikandan R, Islam W, Srinivasan V, Evans CM. Evaluation of extracorporeal shock wave therapy in Peyronie’s disease. Urology 2002; 60: 795–800.

    Article  PubMed  CAS  Google Scholar 

  19. Michel MS, Ptaschynk T, Musial A, et al. Shock wave therapy of Peyronie’s disease: 18 mo follow-up of a prospective study for standardized and objective evaluation of symptom changes under artificial erection [in German]. Akt Urol 2001; 32(suppl 1): 68–71.

    Article  Google Scholar 

  20. Michel MS, Ptaschnyk T, Musial A, et al. Objective and subjective changes in patients with Peyronie’s disease after management with shock wave therapy. J Endourol 2003; 17: 41–44.

    Article  PubMed  Google Scholar 

  21. Mirone V, Imbimbo C, Palmieri A, Fusco F. Our experience on the association of a new physical and medical therapy in patients suffering from induratio penis plastica. Eur Urol 1999; 36: 327–330.

    Article  PubMed  CAS  Google Scholar 

  22. Mirone V, Palmieri A, Granata AM, Piscopo A, Verze P, Ranavolo R. Ultrasound guided extra shock wave treatment of la Peyronie’s disease [in Italian]. Arch Ital Urol Androl 2000; 72: 384–387.

    PubMed  CAS  Google Scholar 

  23. Mirone V, Imbimbo C, Palmieri A, Longo N, Fusco F, Tajana G. A new biopsy technique to investigate Peyronie’s disease associated histologic alterations: results with two different forms of therapy. Eur Urol 2002; 42: 239–244.

    Article  PubMed  Google Scholar 

  24. Oeynhausen D, Oelbracht K, Zumbé J. Extracorporeal shock wave therapy (ESWT) in the treatment of Peyronie’s disease [in German]. Akt Urol 2001; 32(suppl 1): 58–60.

    Article  Google Scholar 

  25. Strebel RT, Suter S, Sautter T, Hauri D. Extracorporeal shock wave therapy for Peyronie’s disease does not correct penile deformity. Int J Impot Res 2004; 16: 448–451.

    Article  PubMed  CAS  Google Scholar 

  26. HauckEW, Mueller UO, BschleipferT, SchmelzHU, DiemerT, WeidnerW. Extracorporeal shockwave therapy for Peyronie’s disease: exploratory metaanalysis of clinical trials. J Urol 2004; 171:740–745.

    Article  PubMed  Google Scholar 

  27. Michel MS, Köhrmann KU, Alken P. Treatment of Peyronie’s disease by shock waves: a critical review [in German]. Aktuel Urol 2001; 32(suppl 1): 65–67.

    Article  Google Scholar 

  28. Groth T, Monga M. Extracorporeal shock wave therapy for Peyronie’s disease. Arch Androl 2003; 49: 205–213.

    Article  PubMed  CAS  Google Scholar 

  29. Iro H, Schneider H, Födra C, et al. Shock wave lithotripsy of salivary duct stones. Lancet 1992; 339: 1333–1336.

    Article  PubMed  CAS  Google Scholar 

  30. Wild C, Khene M, Wanke S. Extracorporeal shock wave therapy in orthopedics. Assessment of an emerging health technology. Int J Technol Assess Health Care 2000; 16: 199–209.

    Article  PubMed  CAS  Google Scholar 

  31. Haupt G. Use of extracorporeal shock waves in the treatment of the pseudarthrosis, tendinopathy and other orthopedic diseases. J Urol 1997; 158: 4–22.

    Article  PubMed  CAS  Google Scholar 

  32. Kadioglu A, Tefekli A, Erol B, et al. Hemodynamic and histopathologic effects of extra-corporeal shockwaves (ESW) on rat penis: preliminary results. Int J Impot Res 2001; 13(suppl 1): S59. Abstract M80.

    Google Scholar 

  33. Rompe JD, Hopf C, Nafe B, Burger R. Low-energy extracorporeal shock wave therapy for painful heel: a prospective controlled single-blind study. Arch Orthop Trauma Surg 1996; 115: 75–79.

    Article  PubMed  CAS  Google Scholar 

  34. Gelbard MK, Dorey F, James K. The natural historyofPeyronie’sdisease. J Urol 1990; 144:1376–1379.

    PubMed  CAS  Google Scholar 

  35. Kadioglu A, Tefekli A, Erol B, Oktar T, Tunc M, Tellaloglu S. A retrospective review of 307 men with Peyronie’s disease. J Urol 2002; 168: 1075–1079.

    Article  PubMed  Google Scholar 

  36. Safarinejad MR. Therapeutic effects of colchicine in the management of Peyronie’s disease: a randomized double-blind, placebo-controlled study. Int J Impot Res 2004; 16: 238–243.

    Article  PubMed  CAS  Google Scholar 

  37. Teloken C, Rhoden EL, Grazziotin TM, Da Ros CT, Sogari PR, Souto CAV. Tamoxifen vs placebo in the treatment of Peyronie’s disease. J Urol 1999; 162: 2003–2005.

    Article  PubMed  CAS  Google Scholar 

  38. Wiltink J, Hauck EW, Phädayanon M, Weidner W, Beutel ME. Validation of the German version of the International Index of Erectile Function (IIEF) in patients with erectile dysfunction, Peyronie’s disease and controls. Int J Impot Res 2003; 15: 192–197.

    Article  PubMed  CAS  Google Scholar 

  39. Weidner W, Hauck EW. Significance of extracorporeal shock-wave therapy (ESWT) in plastic penile induration. Statement of the DGU [in German]. Urologe A 2004; 43: 597–598.

    Article  PubMed  CAS  Google Scholar 

  40. Dillon A. Extracorporeal shockwave therapy for Peyronie’s disease. National Institute of Clinical Excellence. 2003. Available at: http://www.nice.org.uk/IP182overview.

Download references

Author information

Authors and Affiliations

  1. Department of Urology and Pediatric Urology, Justus Liebig University, Giessen, Germany

    Ekkehard W. Hauck MD & Wolfgang Weidner MD

Authors
  1. Ekkehard W. Hauck MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Wolfgang Weidner MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Rush University Medical Center, Chicago, IL

    Laurence A. Levine MD, FACS

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Humana Press Inc., Totowa, NJ

About this chapter

Cite this chapter

Hauck, E.W., Weidner, W. (2007). Extracorporeal Shockwave Therapy in Peyronie’s Disease. In: Levine, L.A. (eds) Peyronie’S Disease. Current Clinical Urology. Humana Press. https://doi.org/10.1007/978-1-59745-161-1_11

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-161-1_11

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-614-6

  • Online ISBN: 978-1-59745-161-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation